Moncef Slaoui
Immunology · Vaccine Development
Philadelphia, Morocco
Overview
Moncef Slaoui is an immunology specialist who led Operation Warp Speed for COVID-19 vaccine development. Oversaw 14 new vaccines at GSK over 30 years. Based in Philadelphia, United States.
For Patients
- Research is cited 3K+ times by other doctors and scientists
- Currently at Operation Warp Speed (US Government) in Philadelphia, Morocco
Biography
Affiliations & Institutions
Research Impact
Publication Timeline
Published In
Key Publications
A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against<i>Plasmodium falciparum</i><i>Malaria</i>
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit Vaccine
Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine
Developing Safe and Effective Covid Vaccines — Operation Warp Speed’s Strategy and Approach
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Legacy Timeline
The life and contributions of Moncef Slaoui
Joined GlaxoSmithKline
Began 30-year career in vaccine development at GSK
Chairman of Global Vaccines at GSK
Led development of 14 new vaccines including Cervarix (HPV) and Mosquirix (malaria)
Chief Scientific Advisor of Operation Warp Speed
Led the US government program that developed COVID-19 vaccines in under a year